For Investors
Technical Diligence.
Risk clarity for capital allocators.
What We Evaluate
Scientific and technical deep-dives to separate robust claims from wishful thinking.
Our team comprises
- PhDs in Chemistry, Materials Science, Tissue Engineering
- Biomedical Engineering, NeuroEngineering, Biology
- Clinicians, Physicians and Surgeons
- Venture Capitalists, Software Engineers
- IP/Patent Attorneys
Our team researches
- Science and medical feasibility
- Regulatory and commercialization hurdles
- Business model and economics
- Competitive analysis
What You Get
Regulatory, product-market, and execution risks surfaced early—not after the check clears.
Questions answered
Real-world validation on market fit, differentiated IP, and scaling potential.
Our team answers
- How much lead time does a company have?
- Is there academic research the company doesn't know of?
- Are the materials and devices on the rising or falling edge of adoption?
- Will surgeons use such technology?
- Will hospitals create friction?
Unbiased diligence.
Operator-led insights into what works, what doesn't, and what's risky.
Clear deliverables.
Risk reports, diligence memos, and actionable recommendations.
Engagement Model
Direct access to senior operators
No salespeople or juniors. We prioritize clear communication, quick onboarding, and milestones tied to investor timelines.
Start with a quick scoping call. We tailor our diligence to your needs and build a focused analytical plan—delivering an actionable risk map and direct recommendations.
Start a conversation